You are here

Solutions

Two new studies indicate Paxlovid's usefulness in helping prevent hospitalization, death in COVID outpatients

Two new studies, one from the United States and one from Canada, suggest that the oral antiviral drug Paxlovid (nirmatrelvir-ritonavir) is effective in lowering the odds of hospitalization or death from the SARS-CoV-2 Omicron subvariant.

...

 

 

 

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Solutions
howdy folks
Page loaded in 1.049 seconds.